|
|
Volumn 11, Issue 1, 2010, Pages 1-3
|
|
Editorial: HTA in Germany: Very special and specific
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMFEBUTAMONE;
CLOPIDOGREL;
DULOXETINE;
MIRTAZAPINE;
VENLAFAXINE;
PRESCRIPTION DRUG;
COST BENEFIT ANALYSIS;
DEPRESSION;
DRUG COST;
EDITORIAL;
GERMANY;
ISCHEMIC HEART DISEASE;
MONOTHERAPY;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
PRIORITY JOURNAL;
ECONOMICS;
HEALTH INSURANCE;
HUMAN;
REIMBURSEMENT;
GERMANY;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
INSURANCE, PHARMACEUTICAL SERVICES;
PRESCRIPTION DRUGS;
|
|
EID: 76649113376
PISSN: 16187598
EISSN: None
Source Type: Journal
DOI: 10.1007/s10198-009-0216-8 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|
